To investigate a possible role of Evi1 in the differential atRA responsiveness of LSCs from LSK- and CMP-derived AML, LCLSK_MLL-AF9 were transduced with shRNAs against Evi1 or with a control shRNA, and transplanted into congenic recipient mice. The gene discussed is KMT2A; the disease is acute myeloid leukemia.